kartosthera.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow:
Meta Tags
Title Home | Kartos
Description Mapping a Path to Breakthrough Kartos Therapeutics is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232),
Keywords N/A
Server Information
WebSite kartosthera faviconkartosthera.com
Host IP 173.231.240.47
Location United States
Related Websites
Site Rank
More to Explore
kartosthera.com Valuation
US$10,719,878
Last updated: 2023-05-09 06:35:53

kartosthera.com has Semrush global rank of 987,353. kartosthera.com has an estimated worth of US$ 10,719,878, based on its estimated Ads revenue. kartosthera.com receives approximately 1,236,909 unique visitors each day. Its web server is located in United States, with IP address 173.231.240.47. According to SiteAdvisor, kartosthera.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$10,719,878
Daily Ads Revenue US$9,896
Monthly Ads Revenue US$296,859
Yearly Ads Revenue US$3,562,298
Daily Unique Visitors 82,461
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
kartosthera.com. A 3600 IP: 173.231.240.47
kartosthera.com. NS 7200 NS Record: ns63.worldnic.com.
kartosthera.com. NS 7200 NS Record: ns64.worldnic.com.
kartosthera.com. MX 3600 MX Record: 10 us-smtp-inbound-1.mimecast.com.
kartosthera.com. MX 3600 MX Record: 10 us-smtp-inbound-2.mimecast.com.
kartosthera.com. TXT 3600 TXT Record: 0ed1fe018aaa60e2c40b6b4905ba4008ea7d3d3524
kartosthera.com. TXT 3600 TXT Record: ZOOM_verify_7zGfg5q4QnCb0tI9biB0qg
kartosthera.com. TXT 3600 TXT Record: docusign=63092d3e-551d-4d45-82da-acb980d33002
kartosthera.com. TXT 3600 TXT Record: v=spf1 include:us._netblocks.mimecast.com include:mail.zendesk.com include:spf.protection.outlook.com -all
kartosthera.com. TXT 3600 TXT Record: geadcfnm62icmjkbcmkf15nd9v
kartosthera.com. TXT 3600 TXT Record: MS=ms62029283
HtmlToTextCheckTime:2023-05-09 06:35:53
Science Research Advocacy About Contact Jobs Mapping a Path to Breakthrough Therapies Dedicated to the development of novel, targeted therapeutics that meaningfully improve the lives of patients with cancer Discover the science MDM2 KRT-232 p53 The MDM2-p53 interaction represents a compelling therapeutic target with potential to provide a new treatment option for patients across selected solid tumors and hematological malignancies Navtemadlin (KRT-232) A novel, potent, and selective oral MDM2 inhibitor Active Clinical Studies KRT-232 MDM2 KARTOS THERAPEUTICS is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232) 275 Shoreline Drive, Suite 300 Redwood City, CA 94065 +1 650.542.0130 info@kartosthera.com © 2023 Kartos Therapeutics Inc Science Navtemadlin (KRT-232) Research Clinical Trials Expanded Access Advocacy About Overview Leadership Contact Jobs Terms of Use Privacy Policy Cookie Policy © 2023 Kartos Therapeutics, Inc. All rights
HTTP Headers
HTTP/1.1 406 Not Acceptable
Date: Sun, 31 Oct 2021 10:12:57 GMT
Server: Apache
Content-Type: text/html; charset=iso-8859-1
kartosthera.com Whois Information
Domain Name: KARTOSTHERA.COM
Registry Domain ID: 2218159166_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-01-26T16:30:06Z
Creation Date: 2018-01-24T21:07:05Z
Registry Expiry Date: 2027-01-24T21:07:05Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS63.WORLDNIC.COM
Name Server: NS64.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T20:06:38Z <<<